Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.36.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.28ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.221.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.242ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.449ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.152ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.146ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.618ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.458ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AG.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.264.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.190ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.552ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.510ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.91ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.227ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.555ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.513ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.4.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XACENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XZENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.5.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FP.2.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JW.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JL.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.571ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.55 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.239ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.574ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.493ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.2 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.352ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.251ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used